纽泰克斯医疗

US · NUTX #2982 按市值排名上市于 1970

186.10 -14.70 -7.32%

实时 - 追踪5344个代码 - 心跳于101秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

机构持股总比例下降了0.3个百分点。

机构持股

机构持股比例: 44.17% -0.31pp
机构数量: 183
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Individual/Insider32.87%

Mutual Fund30.56%

Hedge Fund10.20%

Public Company2.19%

Private Company0.49%

Government Pension Fund0.46%

Family Office/Trust0.24%

Other22.97%

主要股东截至 2026-05-28

Thomas Vo 30.71% · 2.10M 股

Pertento Partners LLP 6.59% · 451.31K 股

BlackRock 5.95% · 407.35K 股

Vanguard Capital Management, LLC 3.68% · 251.89K 股

American Century Investment Management 3.47% · 237.41K 股

Geode Capital Management, LLC 1.93% · 132.05K 股

State Street Global Advisors 1.91% · 130.84K 股

D. E. Shaw & Co., L.P. 1.42% · 97.45K 股

Michael Chang 1.20% · 82.36K 股

UBS Asset Management 1.20% · 82.31K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 39次买入 · 11次卖出

姓名	职务	持股比例
Thomas Vo	Chairperson & CEO	30.71%
Michael Chang	Chief Medical Officer	1.20%
Kelvin Spears	Director	0.51%
Jon Bates	Chief Financial Officer	0.12%
Warren Hosseinion	President	0.11%
Joshua DeTillio	Chief Operating Officer	0.10%
Pamela Montgomery	Chief Legal Officer of Healthcare & Board Secretary	0.04%
Elisa Luqman	Chief Legal Officer (SEC) & Board Secretary	0.03%
Frank Jaumot	Independent Director	0.01%
Cheryl Grenas	Independent Director	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-17	Scott Saunders	Director	Open Market Disposition	-203	$214.25
2026-07-30	Scott Saunders	Director	Derivative Exercise and Retained	+603	--
2026-07-30	Frank Jaumot	Independent Director	Derivative Exercise and Retained	+603	--
2026-07-30	Michael Reed	--	Derivative Exercise and Retained	+603	--
2026-07-30	Cheryl Grenas	Independent Director	Derivative Exercise and Retained	+603	--
2026-06-03	Kelvin Spears	Director	Private Acquisition	+2,519	--
2026-05-27	Thomas Vo	Chairperson & CEO	Private Acquisition	+75,747	--
2026-04-22	Scott Saunders	Director	Other Derivative Acquisition	+823	--
2026-04-22	Frank Jaumot	Independent Director	Other Derivative Acquisition	+823	--
2026-04-22	Michael Reed	--	Other Derivative Acquisition	+823	--
2026-04-22	Cheryl Grenas	Independent Director	Other Derivative Acquisition	+823	--
2026-04-08	Thomas Vo	Chairperson & CEO	Private Acquisition	+184,071	--
2026-03-19	Frank Jaumot	Independent Director	Open Market Acquisition	+150	$93.56
2026-03-18	Warren Hosseinion	President	Open Market Acquisition	+252	$94.07
2026-03-16	Kelvin Spears	Director	Open Market Acquisition	+10	$94.46
2026-03-12	Pamela Montgomery	Chief Legal Officer of Healthcare & Board Secretary	Open Market Acquisition	+79	$88.87
2026-03-10	Jon Bates	Chief Financial Officer	Other Derivative Acquisition	+1,694	--
2026-03-10	Wesley Bamburg	Chief Operating Officer	Other Derivative Acquisition	+2,411	--
2026-03-09	Jon Bates	Chief Financial Officer	Derivative Exercise and Retained	+2,667	--
2026-03-09	Warren Hosseinion	President	Derivative Exercise and Sale	-3,274	$86.22

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。